Identification of stem-like cells in head and neck cancer cell lines

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2005-2010

  Sun, Guangwei ^a   Fujii, Masato ^a   Sonoda, Akira ^b   Tokumaru, Yutaka ^a   Matsunaga, Tatsuo ^a   Habu, Noboru ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Cancer stem cells; Head and neck squamous carcinoma; Side population

Indexed keywords

CELL MARKER;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER STEM LIKE CELL; CELL SELECTION; CELL SUBPOPULATION; CELL TYPE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIDE POPULATION CELL; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD44; ATP-BINDING CASSETTE TRANSPORTERS; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS;

EID: 77955076544     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hunter KD, Parkinson EK and Harrison PR: Opinion - profiling early head and neck cancer. Nat Rev Cancer 5: 127-135, 2005. (Pubitemid 40220338)
2. de Jong RJB, Hermans J, Molenaar J, Briaire JJ and le Cessie S: Prediction of survival in patients with head and neck cancer. Head Neck 23: 718-724, 2001. (Pubitemid 32751487)
3. Eckardt A, Barth EL, Kokemueller H and Wegener G: Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period. Oral Oncol 40: 427-432, 2004. (Pubitemid 38221390)
4. Chen Y-C, Hsu H-S, Chen Y-W, Tsai T-H, How C-K, Wang C-Y, Hung S-C, Chang Y-L, Tsai M-L, Lee Y-Y, Ku H-H and Chiou S-H: Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 3: e2637, 2008.
5. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095, 2008.
6. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997. (Pubitemid 27298715)
7. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
8. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006. (Pubitemid 44623625)
9. Prince MEP and Ailles LE: Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 26: 2871-2875, 2008.
10. Costea DE, Tsinkalovsky O, Vintermyr OK, Johannessen AC and Mackenzie IC: Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis 12: 443-454, 2006.
11. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978, 2007.
12. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G and Masuyama K: Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol 45: 633-639, 2009.
13. Pries R, Wittkopf N, Trenkle T, Nitsch SM and Wollenberg B: Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo 22: 89-92, 2008.
14. Summer R, Kotton DN, Sun X, Ma B, Fitzsimmons K and Fine A: Side population cells and Bcrp1 expression in lung. Am J Physiol-Lung cell Mol Physiol 285: L97-L104, 2003.
15. Lassalle B, Bastos H, Louis JP, Riou L, Testart J, Dutrillaux B, Fouchet P and Allemand I: 'Side population' cells in adult mouse testis express Bcrp1 gene and are enriched in spermatogonia and germinal stem cells. Development. 131: 479-487, 2004.
16. Murayama A, Matsuzaki Y, Kawaguchi A, Shimazaki T and Okano H: Flow cytometric analysis of neural stem cells in the developing and adult mouse brain. J Neurosci Res. 69: 837-847, 2002.
17. Doyle LA and Ross DD: Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 22: 7340-7358, 2003.
18. Challen GA and Ln-Rle MH: A side order of stem cells: The SP phenotype. Stem Cells 24: 3-12, 2006.
19. Scharenberg CW, Harkey MA and Torok-Storb B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99: 507-512, 2002.
20. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H and Sorrentino BP: The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-1034, 2001.
21. Zhou S, Morris JJ, Barnes YX, Lan L, Schuetz JD and Sorrentino BP: Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 99: 12339-12344, 2002.
22. Zhang P, Zhang Y, Mao L, Zhang ZY and Chen WT: Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett 277: 227-234, 2009.
23. Loebinger MR, Giangreco A, Groot KR, Prichard L, Allen K, Simpson C, Bazley L, Navani N, Tibrewal S, Davies D and Janes SM: Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Br J Cancer 98: 380-387, 2008.
24. Harper LJ, Piper K, Common J, Fortune F and Mackenzie IC: Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med 36: 594-603, 2007.
25. Chen JS, Pardo FS, Wang-Rodriguez J, Chu TS, Lopez JP, Aguilera J, Altuna X, Weisman RA and Ongkeko WM: EGFR regulates the side population in head and neck squamous cell carcinoma. Laryngoscope 116: 401-406, 2006.
26. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou JJ, Claypool K and Tang DG: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2(+) and ABCG2(-) cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219, 2005.
27. Seigel GM, Hackam AS, Ganguly A, Mandell LM and Gonzalez-Fernandez F: Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis 13: 823-832, 2007.
28. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V and Yamashita S: Characterization of side population in thyroid cancer cell lines: Cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148: 1797-1803, 2007.
29. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44: 240-251, 2006.
30. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233, 2004.
31. Burkert J, Otto W and Wright N: Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 214: 564-573, 2008.
32. Durand RE and Olive PL: Cytotoxicity, mutagenicity and DNA damage by HOECHST-33342. J Histochem Cytochem 30: 111-116, 1982.
33. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
34. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951, 2005.
35. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007.
36. Krishnadath KK, Tilanus HW, vanBlankenstein M, Hop WCJ, Kremers ED, Dinjens WNM and Bosman FT: Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182: 331-338, 1997.
37. Bremnes RM, Veve R, Hirsch FR and Franklin WA: The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36: 115-124, 2002.
38. Zhao XJ, Li H, Chen H, Liu YX, Zhang LH, Liu SX and Feng QL: Expression of E-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol 9: 225-232, 2003.
39. Valk-Lingbeek ME, Bruggeman SWM and Van Lohuizen M: Stem cells and cancer: The polycomb connection. Cell 118: 409-418, 2004.
40. Diestra JE, Scheffer GL, Catala I, Maleipaad M, Schellens JHM, Scheper RJ, Germa-Lluch JR and Izquierdo MA: Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol 198: 213-219, 2002.
41. Li CW, Heidt DG, Dalerba P, Burant CF, Zhang LJ, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
42. Montanaro F, Liadaki K, Schienda J, Flint A, Gussoni E and Kunkel LM: Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res 298: 144-154, 2004.
43. Minor DR, Monroe D, Damico LA, Meng G, Suryadevara U and Elias L: A phase II study of thalidomide in advanced metastatic renal cell carcinoma. Invest New Drugs 20: 389-393, 2002.
44. Mack B and Gires O: CD44s and CD44v6 expression in head and neck epithelia. PLoS ONE. 3: Article No.: e3360, 2008.